Syntiron

Business Services · Minnesota, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1000 Westgate Dr Ste 162, Saint Paul, Mi...

Phone Number

(651) 641-2876

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Syntiron

Syntiron is a human vaccine research firm focused on developing vaccines to combat antimicrobial resistance (AMR), particularly targeting urinary tract infections (UTIs) and neonatal sepsis. Their ALLOY Vaccine Platform utilizes a novel approach to create strong, broadly protective vaccines by targeting multiple bacterial iron receptors. The company aims to reduce antimicrobial use globally and address the growing threat of AMR, which is projected to become a leading cause of death worldwide. Syntiron's innovative technology allows for the efficient production of vaccines that can save lives across all age groups.Explore more
Syntiron's Social MediaPopular SearchesSyntironsyntiron LLCSyntiros LLCSIC Code 87,873NAICS Code 54,541Show more

Syntiron Org Chart

RS
United States flag for contact location.

Chief Executive Officer

PhoneEmail
BW
United States flag for contact location.

Chief Financial Officer, Member

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Syntiron your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Syntiron

Compare insights from companies similar to Syntiron, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Syntiron

<$5M
11-50
Private
-
2004
$13.9M
11-50
Private
-
-
N/A
$11.1M
11-50
Private
<$5M
2005
Patty Ferrante, Chief Operating Officer at Melior Discovery
Patty FerranteChief Operating Officer
$5.3M
11-50
Private
$83.5M
2005
<$5M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
2015
11-50
Public
$199.6M
1996
James Caruso, President, Chief Executive Officer & Director at Cellectar Biosciences
James CarusoPresident, CEO & Director
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Syntiron is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Syntiron is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Syntiron.

Syntiron Tech Stack

Top Business Services Companies

Frequently Asked Questions Regarding Syntiron

What is Syntiron's official website?
Syntiron's official website is www.syntiron.com
What is Syntiron's Revenue?
Syntiron's revenue is <$5 Million
What is Syntiron's SIC code?
Syntiron's SIC: 87,873
What is Syntiron's NAICS code?
Syntiron's NAICS: 54,541
How many employees does Syntiron have?
Syntiron has 11-50 employees
What industry does Syntiron belong to?
Syntiron is in the industry of: Business Services, Research & Development
What is Syntiron competition?
Syntiron top competitors include: Revitope Oncology, Prothix, Cellectar Biosciences, Immunomic Therapeutics
What technology does Syntiron use?
Some of the popular technologies that Syntiron uses are: Google Cloud Web Serving, Google Cloud Platform, Microsoft 365, Microsoft Exchange Online
Who is the CFO of Syntiron?
Syntiron's CFO is Beth Wosmek
How do I contact Syntiron?
Syntiron contact info: Phone number: (651) 641-2876 Website: www.syntiron.com
What does Syntiron do?

Syntiron is a human vaccine research firm focused on developing vaccines to combat antimicrobial resistance (AMR), particularly targeting urinary tract infections (UTIs) and neonatal sepsis. Their ALLOY Vaccine Platform utilizes a novel approach to create strong, broadly protective vaccines by targeting multiple bacterial iron receptors. The compan... y aims to reduce antimicrobial use globally and address the growing threat of AMR, which is projected to become a leading cause of death worldwide. Syntiron's innovative technology allows for the efficient production of vaccines that can save lives across all age groups.Read More

What are Syntiron social media links?
Syntiron Linkedin page Syntiron Twitter page
Is Syntiron a public company?
Syntiron is private company therefore does not currently have an official ticker symbol
See more information about Syntiron

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.